Letter from Willey and Biviano Regarding Article, “Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We read the results of the AATAC trial (Ablation vs Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients with Congestive Heart Failure and an Implanted ICD/CRTD)1 as a stroke neurologist (Dr Willey) and cardiac electrophysiologist (Dr Biviano) with interest. The primary outcomes concerned improvements in heart failure–related symptoms, …